Tumour burden and efficacy of immune-checkpoint inhibitors

医学 癌症 生物标志物 疾病负担 代理终结点 免疫疗法 肿瘤科 免疫检查点 免疫系统 内科学 生物信息学 疾病 免疫学 生物化学 生物 化学
作者
Filippo Gustavo Dall’Olio,Aurélien Marabelle,Caroline Caramella,Camilo Garcia,Mihaela Aldea,Nathalie Chaput,Caroline Robert,Benjamin Besse
出处
期刊:Nature Reviews Clinical Oncology [Nature Portfolio]
卷期号:19 (2): 75-90 被引量:332
标识
DOI:10.1038/s41571-021-00564-3
摘要

Accumulating evidence suggests that a high tumour burden has a negative effect on anticancer immunity. The concept of tumour burden, simply defined as the total amount of cancer in the body, in contrast to molecular tumour burden, is often poorly understood by the wider medical community; nonetheless, a possible role exists in defining the optimal treatment strategy for many patients. Historically, tumour burden has been assessed using imaging. In particular, CT scans have been used to evaluate both the number and size of metastases as well as the number of organs involved. These methods are now often complemented by metabolic tumour burden, measured using the more recently developed 2-deoxy-2-[18F]-fluoro-D-glucose (FDG)-PET/CT. Serum-based biomarkers, such as lactate dehydrogenase, can also reflect tumour burden and are often also correlated with a poor response to immune-checkpoint inhibitors. Other circulating markers (such as circulating free tumour DNA and/or circulating tumour cells) are also attracting research interest as surrogate markers of tumour burden. In this Review, we summarize evidence supporting the utility of tumour burden as a biomarker to guide the use of immune-checkpoint inhibitors. We also describe data and provide perspective on the various tools used for tumour burden assessment, with a particular emphasis on future therapeutic strategies that might address the issue of inferior outcomes among patients with cancer with a high tumour burden.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
刚刚
jing发布了新的文献求助10
1秒前
1秒前
3419549959完成签到,获得积分10
2秒前
2秒前
2秒前
AAA发布了新的文献求助10
3秒前
3秒前
香蕉觅云的应助被特仑苏采纳,获得10
4秒前
爱吃秋刀鱼的大脸猫完成签到,获得积分10
4秒前
NiNi发布了新的文献求助10
5秒前
黑米粥发布了新的文献求助200
6秒前
6秒前
7秒前
桃子汽水发布了新的文献求助10
7秒前
苏小满关注了科研通微信公众号
8秒前
彭泽阳完成签到,获得积分10
8秒前
干就完发布了新的文献求助10
8秒前
8秒前
不开花花发布了新的文献求助10
9秒前
9秒前
李元发布了新的文献求助10
10秒前
10秒前
11秒前
11秒前
12秒前
12秒前
12秒前
Even完成签到,获得积分10
12秒前
Seorina发布了新的文献求助20
12秒前
12秒前
13秒前
13秒前
13秒前
领导范儿的应助被xiaoqiao采纳,获得30
14秒前
田様的应助被夏目采纳,获得10
14秒前
14秒前
FashionBoy的应助被包容河马采纳,获得10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183880
求助须知:如何正确求助?哪些是违规求助? 9573054
关于积分的说明 21828982
捐赠科研通 7780959
什么是DOI,文献DOI怎么找? 3434134
关于科研通互助平台的介绍 2558315
邀请新用户注册赠送积分活动 2480634